Tenon Medical (TNON) Net Equity Issued and Repurchased (2023 - 2025)

Tenon Medical has reported Net Equity Issued and Repurchased for 3 years, with the latest figure at $4.0 million in Q1 2025.

• On a quarterly basis, Net Equity Issued and Repurchased rose 53.93% year-over-year to $4.0 million in Q1 2025; TTM through Jun 2025 was $4.0 million, a 334.78% increase from a year earlier, with the FY2024 full-year figure at $2.6 million, up 426.26% from the prior year.
• Net Equity Issued and Repurchased was $4.0 million for Q1 2025 at Tenon Medical, up from $2.6 million in the prior quarter.
• The five-year high for Net Equity Issued and Repurchased was $4.0 million in Q1 2025, with the low at -$4.4 million in Q3 2023.
• Average Net Equity Issued and Repurchased over 3 years is $575500.0, with a median of $1.3 million recorded in 2023.
• The largest YoY upside for Net Equity Issued and Repurchased was 53.93% in 2025 against a maximum downside of 53.93% in 2025.
• Over 3 years, Net Equity Issued and Repurchased stood at $42000.0 in 2023, then surged by 6102.38% to $2.6 million in 2024, then surged by 53.93% to $4.0 million in 2025.
• The last three Net Equity Issued and Repurchased figures came in at $4.0 million (Q1 2025), $2.6 million (Q1 2024), and $42000.0 (Q4 2023), per Business Quant data.